| scholarly article | Q13442814 |
| P50 | author | Eric J Downer | Q61141093 |
| P2093 | author name string | Andrew Smith | |
| Marina A Lynch | |||
| Anthony Lyons | |||
| Aileen M Lynch | |||
| Joan B O'Sullivan | |||
| Riona Hanley | |||
| P2860 | cites work | IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia | Q40841314 |
| Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons | Q39980554 | ||
| Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities | Q40605174 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microglia | Q1622829 |
| P304 | page(s) | 1547-1556 | |
| P577 | publication date | 2009-07-15 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro | |
| P478 | volume | 110 |
| Q37310521 | A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders |
| Q42682338 | Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death |
| Q36052653 | Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences |
| Q21128630 | Age-related neuroinflammatory changes negatively impact on neuronal function |
| Q41683967 | Alterations in the Interplay between Neurons, Astrocytes and Microglia in the Rat Dentate Gyrus in Experimental Models of Neurodegeneration |
| Q26778149 | Alzheimer's Disease: Mechanism and Approach to Cell Therapy |
| Q47175712 | Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy |
| Q30360306 | Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. |
| Q41537684 | Are inflammatory profiles the key to personalized Alzheimer's treatment? |
| Q52641302 | Aspirin modulates the inflammatory response in a thrombus‑stimulated LMVEC model. |
| Q59349485 | CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model |
| Q45325019 | CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents |
| Q21129473 | CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity |
| Q34576624 | CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. |
| Q26739374 | CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection |
| Q39015586 | CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway |
| Q39185958 | Chemokine fractalkine attenuates overactivation and apoptosis of BV-2 microglial cells induced by extracellular ATP. |
| Q37935622 | Cognitive and behavioral consequences of impaired immunoregulation in aging |
| Q91618150 | Cx3cr1-deficient microglia exhibit a premature aging transcriptome |
| Q42143711 | Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1. |
| Q34973138 | Differential modulation of TREM2 protein during postnatal brain development in mice. |
| Q33887236 | Diminished brain resilience syndrome: A modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration |
| Q37812669 | Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation |
| Q41623712 | Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus |
| Q36266430 | Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection. |
| Q36889750 | Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress |
| Q92575793 | Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells |
| Q34503290 | Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression |
| Q38530348 | Fractalkine in the nervous system: neuroprotective or neurotoxic molecule? |
| Q35591414 | Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration |
| Q34478106 | Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide |
| Q50935908 | Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS. |
| Q37209413 | Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice |
| Q37652175 | Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina |
| Q93339877 | High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss |
| Q36195292 | Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke. |
| Q89792753 | Imipramine and Venlafaxine Differentially Affect Primary Glial Cultures of Prenatally Stressed Rats |
| Q34213029 | Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis |
| Q37188834 | Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand |
| Q36561722 | Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. |
| Q99565713 | Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation |
| Q35576920 | Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation |
| Q35785441 | Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice |
| Q64103822 | Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain |
| Q47844298 | Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes |
| Q27009559 | Microglia centered pathogenesis in ALS: insights in cell interconnectivity |
| Q90206387 | Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities |
| Q37710380 | Microglia in neurodegenerative disease |
| Q36678453 | Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation |
| Q34359569 | Microglial phenotype and adaptation |
| Q34997832 | Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. |
| Q34019783 | Modulating neurotoxicity through CX3CL1/CX3CR1 signaling |
| Q37949275 | Mucosal macrophages in intestinal homeostasis and inflammation |
| Q34002086 | Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles |
| Q38166592 | Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity |
| Q64237341 | Neuroinflammation and fractalkine signaling in Alzheimer's disease |
| Q37941009 | Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain. |
| Q37424844 | Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage |
| Q33624540 | Old Maids: Aging and Its Impact on Microglia Function |
| Q92856462 | Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke |
| Q36182897 | Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling. |
| Q34127089 | Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge |
| Q38049597 | Review: microglia of the aged brain: primed to be activated and resistant to regulation |
| Q38764818 | Rod-shaped microglia morphology is associated with aging in 2 human autopsy series |
| Q90230624 | Stress and aging act through common mechanisms to elicit neuroinflammatory priming |
| Q36984247 | Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice. |
| Q26744219 | Targeting innate immunity for neurodegenerative disorders of the central nervous system |
| Q47161248 | The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression |
| Q39424451 | The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity |
| Q39149587 | The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. |
| Q91750672 | The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit |
| Q35806715 | The impact of glial activation in the aging brain |
| Q38123243 | The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease. |
| Q37560782 | The multifaceted profile of activated microglia. |
| Q27318419 | The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus |
| Q36409902 | The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. |
| Q41475535 | Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage |
| Q38484760 | Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system |
| Q26741931 | With mouse age comes wisdom: A review and suggestions of relevant mouse models for age-related conditions |
Search more.